The authors intertwine research from biological, clinical and medicinal chemistry disciplines to discuss historical and current RGD-binding integrin drug discovery, with an emphasis on small-molecule inhibitors of the αv integrins.
[Nature Reviews Drug Discovery]
7992332
{7992332:AAAAAAAA}
apa
50
1
166909
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
